Share
Market Research Report

MENSTRUAL CRAMPS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassAnalgesics · Anticholinergics · Non-steroidal anti-inflammatory drugs · Haematinics · and Others (Progestins, Among others)
  • By TypePrimary Dysmenorrhea and Secondary Dysmenorrhea
  • By Route of AdministrationOral · Injectable · Topical · Intrauterine · and Others (Intrauterine, Among others)
  • By Dosage FormTablet · Capsules · Suspension · and Others (Transdermal Patch, Among others)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • Published In29 Apr 2026
  • Report CodeCMI5760
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Type
      • Market Snapshot, By Route of administration
      • Market Snapshot, By Dosage Form
      • Market Snapshot, By Distribution channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Attractiveness Analysis
      • Market Opportunities
    • Product Launches
    • Market Trends
    • Merger, Acquisition, Collaborations
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • Technology Landscape
    • Pricing Analysis
    • Brand Analysis
    • Investments and Funding
    • Facility Expansions
  4. Global Menstrual Cramps Treatment Market, By Drug Class, 2021–2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Anticholinergics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Non-steriodal anti-inflammatory drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Haematinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Others (Progestins, Among others)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  5. Global Menstrual Cramps Treatment Market, By Type, 2021 - 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Primary Dysmenorrhea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    •  Secondary Dysmenorrhea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  6. Global Menstrual Cramps Treatment Market, By Route of administration, 2021 - 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Others (Intrauterine, Among others)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  7. Global Menstrual Cramps Treatment Market, By Dosage Form, 2021 - 2033, (US$ Million)

    • Tablet
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Capsules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Suspension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Others (Transdermal Patch, Among others)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  8. Global Menstrual Cramps Treatment Market, By Distribution channel, 2021 - 2033, (US$ Million)

    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Million)
  9. Global Menstrual Cramps Treatment Market, By Region, 2021 - 2033, (US$ Million)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape

    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cipla Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Reddy’s Laboratories Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Almatica Pharma LLC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlaxoSmithKline Plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eisen Pharmaceutical Co. (Pvt.) Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Emcure Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AbbVie
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sparsha Pharma International Pvt Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hope Medicine (Nanjing) Co., Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  11. Section

    • Research Methodology
    • About Us

*Browse 33 market data tables and 26 figures on “Global Menstrual Cramps Treatment Market”- Global forecast to 2033